K-V Pharmaceutical Co - FORM 10-K - EX-21 - LIST OF SUBSIDIARIES - March 25, 2010

Attached files

file filename
10-K - FORM 10-K - K-V Pharmaceutical Cod10k.htm
EX-3.1 - CERTIFICATE OF INCORPORATION - K-V Pharmaceutical Codex31.htm
EX-23.1 - CONSENT OF KPMG LLP - K-V Pharmaceutical Codex231.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 - K-V Pharmaceutical Codex321.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) - K-V Pharmaceutical Codex312.htm
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 - K-V Pharmaceutical Codex322.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) - K-V Pharmaceutical Codex311.htm
EX-10.41 - AGREEMENT AND RELEASE - K-V Pharmaceutical Codex1041.htm
EX-10.30 - SEPARATION AGREEMENT AND GENERAL RELEASE - K-V Pharmaceutical Codex1030.htm
EX-10.13 - FORM OF INCENTIVE STOCK OPTION AGREEMENT - K-V Pharmaceutical Codex1013.htm
EX-10.42 - FOURTH AMENDMENT TO EMPLOYMENT AND CONFIDENTIAL INFORMATION AGREEMENT - K-V Pharmaceutical Codex1042.htm
EX-10.31 - CONSULTING AND CONFIDENTIALITY AGREEMENT - K-V Pharmaceutical Codex1031.htm
EX-10.48 - AMENDMENT, DATED JANUARY 8, 2010, TO THE ASSET PURCHASE AGREEMENT - K-V Pharmaceutical Codex1048.htm
EX-10.38 - EMPLOYMENT AGREEMENT - K-V Pharmaceutical Codex1038.htm
EX-10.14 - FORM OF NONQUALIFIED STOCK OPTION AGREEMENT FOR GRANTS TO EMPLOYEES - K-V Pharmaceutical Codex1014.htm
EX-10.15 - FORM OF NONQUALIFIED STOCK OPTION AGREEMENT FOR GRANTS TO DIRECTORS - K-V Pharmaceutical Codex1015.htm

Exhibit 21

Subsidiaries of the Registrant

 

Name

   

Jurisdiction of Organization

DrugTech Corporation

    Delaware

DrugTech SARL (Switzerland)

    Switzerland

ETHEX Corporation

    Missouri

FP1096, Inc.

    Pennsylvania

KV Pharmaceutical Company Limited (UK)

    United Kingdom

MECW, LLC

    Delaware

Nesher Solutions Ltd. (Israel)

    Israel

Nesher Solutions USA, Inc.

    Delaware

Particle Dynamics, Inc.

    New York

Ther-Rx Corporation

    Missouri

Zeratech Technologies USA, Inc.

    Delaware

K-V Pharmaceutical Co Reports